BioStem Technologies Capital Expenditures (CapEx) Growth & History (BSEM)

BioStem Technologies's capital expenditures (capex) was $0 for fiscal 2025.

View full BioStem Technologies company overview

BioStem Technologies annual capital expenditures (capex) history

BioStem Technologies annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$0$0
20242024-12-31$0−$210,330
20232023-12-31$210,330−$259,154−55.20%
20222022-12-31$469,484$426,636+995.70%
20212021-12-31$42,848

BioStem Technologies capital expenditures (capex) trends

Between the periods ended 2021-12-31 and 2025-12-31, BioStem Technologies's capital expenditures (capex) decreased from $42,848 to $0, a change of −$42,848. The latest reported quarter, Q2 2026, shows $57,925.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioStem Technologies source filings ↗

Community posts

It’s quiet here.

No posts about BSEM yet. Start the conversation.

Write the first post